Cathepsin expression during skeletal development

被引:64
作者
Söderström, M
Salminen, H
Glumoff, V
Kirschke, H
Aro, H
Vuorio, E
机构
[1] Univ Turku, Dept Med Biochem & Mol Biol, Skeletal Res Program, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Surg, FIN-20520 Turku, Finland
[3] Univ Halle, Inst Physiol Chem, D-06097 Halle, Germany
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 1999年 / 1446卷 / 1-2期
基金
芬兰科学院;
关键词
cathepsin; collagen; extracellular matrix; human; osteoclast; mouse; mRNA;
D O I
10.1016/S0167-4781(99)00068-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cysteine proteinases, cathepsins B, H, K, L and S, have been implicated in several proteolytic processes during development, growth, remodeling and aging, as well as in a variety of pathological processes. For systematic analysis of cathepsin gene expression we have produced cDNA clones for mouse and human cysteine cathepsins. Northern analysis of a panel of total RNAs isolated from 16-19 different human and mouse tissues revealed the presence of mRNAs for cathepsin B, H, K, L and S in most tissues, but each with a distinct profile. Of the different cathepsin mRNAs, those for cathepsin K were clearly the highest in bone and cartilage. However, relatively high mRNA levels for the other cathepsins were also present in these tissues. To better understand the roles of different cathepsins during endochondral ossification in mouse long bones, cathepsin mRNAs were localized by in situ hybridization. Cathepsin K mRNAs were predominantly seen in multinucleated chondroclastic and osteoclastic cells at the osteochondral junction and on the surface of bone spicules. The other cathepsin mRNAs were also seen in osteoclasts, and in hypertrophic and proliferating chondrocytes. These observations were confirmed by immunohistochemistry and suggest that all cysteine cathepsins are involved in matrix degradation during endochondral ossification. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 59 条
[31]   Molecular cloning of a novel mouse aspartic protease-like protein that is expressed abundantly in the kidney [J].
Mori, K ;
Ogawa, Y ;
Tamura, N ;
Ebihara, K ;
Aoki, T ;
Muro, S ;
Ozaki, S ;
Tanaka, I ;
Tashiro, K ;
Nakao, K .
FEBS LETTERS, 1997, 401 (2-3) :218-222
[32]  
Murphy Gillian, 1993, P287
[33]   Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus [J].
Nakagawa, T ;
Roth, W ;
Wong, P ;
Nelson, A ;
Farr, A ;
Deussing, J ;
Villadangos, JA ;
Ploegh, H ;
Peters, C ;
Rudensky, AY .
SCIENCE, 1998, 280 (5362) :450-453
[34]   LYSOSOMAL CYSTEINE AND ASPARTIC PROTEINASES, ACID-PHOSPHATASE, AND AN ENDOGENOUS CYSTEINE PROTEINASE-INHIBITOR, CYSTATIN-BETA, IN RAT OSTEOCLASTS [J].
OHSAWA, Y ;
NITATORI, T ;
HIGUCHI, S ;
KOMINAMI, E ;
UCHIYAMA, Y .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (07) :1075-1083
[35]   DEGRADATION OF BONE-MATRIX PROTEINS BY OSTEOCLAST CATHEPSINS [J].
PAGE, AE ;
HAYMAN, AR ;
ANDERSSON, LMB ;
CHAMBERS, TJ ;
WARBURTON, MJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1993, 25 (04) :545-550
[36]  
PETANCESKA S, 1992, J BIOL CHEM, V267, P26038
[37]  
PORTNOY DA, 1986, J BIOL CHEM, V261, P4697
[38]  
QIAN F, 1989, CANCER RES, V49, P4870
[39]   Mouse cathepsin K: cDNA closing and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development [J].
Rantakokko, J ;
Aro, HT ;
Savontaus, M ;
Vuorio, E .
FEBS LETTERS, 1996, 393 (2-3) :307-313
[40]  
RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461